The FOXP3+ Pro-Inflammatory T Cell: A Potential Therapeutic Target in Crohn’s Disease-Reference-Cited by-同舟云学术

The FOXP3+ Pro-Inflammatory T Cell: A Potential Therapeutic Target in Crohn’s Disease

Published:2024-04 Issue:4 Volume:166 Page:631-644.e17
ISSN:0016-5085
Container-title:Gastroenterology
language:en
Short-container-title:Gastroenterology

Author:

Kosinsky Robyn Laura,Gonzalez Michelle M.,Saul Dominik,Barros Luísa Leite,Sagstetter Mary R.,Fedyshyn Yaroslav,Nair Asha,Sun Zhifu,Hamdan Feda H.,Gibbons Hunter R.,Perez Pachon Mauricio E.,Druliner Brooke R.,Johnsen Steven A.,Faubion William A.

Funder

Deutsche Krebshilfe

National Institutes of Health

National Institute of Diabetes and Digestive and Kidney Diseases

AGA Research Foundation

National Center for Advancing Translational Sciences

Deutsche Forschungsgemeinschaft

Publisher

Elsevier BV

Reference36 articles.

1. The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017;Lancet Gastroenterol Hepatol,2020

2. Single-cell analyses of Crohn's disease tissues reveal intestinal intraepithelial T cells heterogeneity and altered subset distributions;Jaeger;Nat Commun,2021

3. CD4 T cells in IBD: crossing the line?;Boden;Dig Dis Sci,2017

4. CD4 T-cell differentiation and inflammatory bowel disease;Zenewicz;Trends Mol Med,2009

5. Differential mucosal expression of Th17-related genes between the inflamed colon and ileum of patients with inflammatory bowel disease;Bogaert;BMC Immunol,2010

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Spectrum of Treg and self-reactive T cells: single cell perspectives from old friend HTLV-1;Discovery Immunology;2024-01-01